3,452 reports of this reaction
4.2% of all INSULIN HUMAN reports
#2 most reported adverse reaction
BLOOD GLUCOSE DECREASED is the #2 most commonly reported adverse reaction for INSULIN HUMAN, manufactured by Eli Lilly and Company. There are 3,452 FDA adverse event reports linking INSULIN HUMAN to BLOOD GLUCOSE DECREASED. This represents approximately 4.2% of all 82,903 adverse event reports for this drug.
Patients taking INSULIN HUMAN who experience blood glucose decreased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BLOOD GLUCOSE DECREASED is moderately reported among INSULIN HUMAN users, representing a notable but not dominant share of adverse events.
In addition to blood glucose decreased, the following adverse reactions have been reported for INSULIN HUMAN:
The following drugs have also been linked to blood glucose decreased in FDA adverse event reports:
BLOOD GLUCOSE DECREASED has been reported as an adverse event in 3,452 FDA reports for INSULIN HUMAN. This does not prove causation, but indicates an association observed in post-market surveillance data.
BLOOD GLUCOSE DECREASED accounts for approximately 4.2% of all adverse event reports for INSULIN HUMAN, making it one of the most commonly reported side effect.
If you experience blood glucose decreased while taking INSULIN HUMAN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.